Drug Type Small molecule drug |
Synonyms SL |
Target |
Action stimulants, agonists |
Mechanism GLUT1 stimulants(Glucose transporter 1 stimulants), GLUT2 agonists(solute carrier family 2 member 2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Preclinical | China | 08 Dec 2025 |





